Koninklijke Philips (NYSE:PHG) Receives Consensus Rating of “Hold” from Brokerages

Shares of Koninklijke Philips (NYSE:PHG) have earned an average recommendation of “Hold” from the five ratings firms that are currently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company.

Several equities analysts have recently weighed in on the stock. Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. StockNews.com lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th.

Koninklijke Philips Stock Up 0.3 %

NYSE PHG opened at $25.82 on Friday. The business has a fifty day moving average price of $25.85 and a 200 day moving average price of $28.05. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. Koninklijke Philips has a one year low of $19.55 and a one year high of $32.91.

Institutional Investors Weigh In On Koninklijke Philips

A number of hedge funds have recently modified their holdings of PHG. Fairscale Capital LLC acquired a new position in Koninklijke Philips in the 2nd quarter valued at about $54,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Koninklijke Philips during the 3rd quarter valued at approximately $54,000. Eastern Bank acquired a new position in Koninklijke Philips in the third quarter valued at approximately $88,000. RPg Family Wealth Advisory LLC purchased a new position in Koninklijke Philips in the third quarter worth approximately $107,000. Finally, Headlands Technologies LLC increased its stake in Koninklijke Philips by 43.9% during the second quarter. Headlands Technologies LLC now owns 6,561 shares of the technology company’s stock worth $165,000 after acquiring an additional 2,003 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.